Company Overview - Vistin Pharma ASA is a Norwegian pharmaceutical company specializing in the production of Metformin Hydrochloride (API) and Direct Compressible lubricated granules [2] - The company is a dedicated European Metformin producer, positioning itself as a key supplier to leading pharmaceutical companies [2] - Vistin Pharma is headquartered in Oslo, Norway, and operates a dedicated manufacturing facility in Kragerø with a team of highly qualified employees [2] Upcoming Financial Results - Vistin Pharma will release its fourth quarter and preliminary 2025 results on February 12, 2025 [1] - A conference call for shareholders and interested parties will take place on the same day at 08:30 CET, including a Q&A session following the management discussion [1] - The conference call will be conducted in English and will be accessible via web and audio [1]

Company Overview - Vistin Pharma ASA (VISTN) is a Norwegian pharmaceutical company specializing in the production of Metformin Hydrochloride (API) and Direct Compressible lubricated granules [2] - The company is a dedicated European Metformin producer, positioning itself as a key supplier to leading pharmaceutical companies [2] Upcoming Financial Results - Vistin Pharma will release its third quarter and year-to-date 2025 results on October 31, 2025 [1] - A conference call for shareholders and interested parties will take place on the same day at 08:30 CET, including a Q&A session following the management discussion [1] Communication Channels - The conference call will be available via web and audio, with specific access points provided for participants [1][2] - For further inquiries, contact information for the CFO, Alexander Karlsen, is available [2]

Company Overview - Vistin Pharma ASA is a Norwegian pharmaceutical company specializing in the production of Metformin Hydrochloride (API) and Direct Compressible lubricated granules [3] - The company is a dedicated European Metformin producer, positioning itself as a key supplier to leading pharmaceutical companies [3] Upcoming Financial Results - Vistin Pharma will release its second quarter and year-to-date 2025 results on August 15, 2025 [1] - A conference call for shareholders and interested parties will take place on the same day at 08:30 CET, including a Q&A session following the management discussion [1] Communication Channels - The conference call will be accessible via web and audio through specified access points [1] - Webcast and telephone conference registration links are provided for participants [2]